HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-(Piperidin-4-YL)-1H-indazole → 4-(1-(4-Cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)-3-fluoroazetidin-3-yl)benzonitrile
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-(Piperidin-4-YL)-1H-indazole | HCID 49760859 | — |
| Reactant | 4-(3-Fluoroazetidin-3-yl)benzonitrile hydrochloride | HCID 90021334 | — |
| Reactant | 4-Cyclobutyl-2-methyl-5-(methylcarbamoyl)benzoic acid | HCID 90022051 | — |
| Reactant | HCID 178433965 | HCID 178433965 | — |
| Product | 4-(1-(4-Cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)-3-fluoroazetidin-3-yl)benzonitrile | HCID 178433964 | — |
Reaction Steps
The title compound was prepared using standard chemical manipulations and procedures similar to those used for the preparation of compound 62, except 4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoic acid (compound 78.4) was used in place of 4-cyclobutyl-2-methyl-5-(methylcarbamoyl)benzoic acid (compound 62.3) and 4-(3-fluoroazetidin-3-yl)benzonitrile hydrochloride (compound 43.4) was used in place of 5-(piperidin-4-yl)-1H-indazole (compound 62.5). m/z (ES+) 430 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09428502B2 |
| Source dataset | uspto-grants-2016_08 |
| ORD ID | ord-bdfae158759d4788bd4efca37f8abb66 |
| Source note | uspto-grants-2016_08 |